Home > Financial Ratios > ALKEM LABORATORIES

ALKEM LABORATORIES
Core EBITDA Growth

    Back to All Ratios
ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ALKEM LABORATORIES
Please provide your vote to see the results

ALKEM LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 19.3817.5940.03-17.601.84

What is the latest Core EBITDA Growth ratio of ALKEM LABORATORIES ?

The latest Core EBITDA Growth ratio of ALKEM LABORATORIES is 19.38 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202619.38
Mar202517.59
Mar202440.03
Mar2023-17.60
Mar20221.84

How is Core EBITDA Growth of ALKEM LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2026 19.38
10.18
Mar2025 17.59
-56.06
Mar2024 40.03
Positive
Mar2023 -17.6
Negative
Mar2022 1.84 -

Other Financial Ratios of ALKEM LABORATORIES


Compare Core EBITDA Growth ratio of peers of ALKEM LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALKEM LABORATORIES ₹65,899.6 Cr -2.7% -1.2% 12.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,471.0 Cr -0.5% 0.8% 19% Stock Analytics
DIVIS LABORATORIES ₹226,631.0 Cr 2.2% 23.1% 27.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,157.0 Cr -2.6% -1.6% 36% Stock Analytics
CIPLA ₹118,108.0 Cr 0.8% 2.5% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,578.0 Cr 2.6% -2.4% -5.6% Stock Analytics


ALKEM LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALKEM LABORATORIES

-2.7%

-1.2%

12.9%

SENSEX

-0.4%

0.8%

-3%


You may also like the below Video Courses